Virtual: Pharma Japan 2020

Featured Session

Listening to the Patient Voice in APAC

September 2nd | 10:00am - 11:00am

• Patient centricity is fast becoming the “new normal” in the biopharma industry
• Engaging with patients, actively listening and incorporating their insights adds value throughout all phases of drug development
• Patient centricity is optimized when implemented across all disciplines including clinical development, medical affairs, market access, outcomes research and commercialization.

Presented by: Bruce Crawford, MA, MPH, Vice President, Real World & Late Phase